Loring Wolcott & Coolidge Fiduciary Advisors LLP Amarin Corp Plcuk Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$11.1 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.94 - $5.84 $6,288 - $9,320	-1,596 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$4.26 - $6.5 $6,798 - $10,374	1,596 New	1,596 $7,000
Q1 2021 Apr 14, 2021	SELL	$5.03 - $8.8 $33,509 - $58,625	-6,662 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$13.89 - $23.16 $92,549 - $154,315	-6,663 Reduced 50.0%	6,662 $101,000
Q2 2017 Aug 07, 2017	BUY	N/A	13,325	13,325 $0

Others Institutions Holding AMRN

# of Institutions

177

Shares Held

65.1M

Call Options Held

258K

Put Options Held

98K

Sarissa Capital Management LP Greenwich, CT

24.9M
Shares

$11.4 Million
3.89% of portfolio
Kynam Capital Management, LP Princeton, NJ

12.4M
Shares

$5.71 Million
0.64% of portfolio
Eversept Partners, LP New York, NY

3.31M
Shares

$1.52 Million
0.16% of portfolio
Morgan Stanley New York, NY

2.55M
Shares

$1.17 Million
0.0% of portfolio
Scp Investment, LP

2.5M
Shares

$1.15 Million
1.16% of portfolio

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $185M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account